Follow-The-Filings

Security · featured owners

PRME

Prime Medicine Inc. COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.2%
  • $35M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Cathie Wood - Ark Investm...) · not free-float ownership

  1. Cathie Wood add 0.2%
  2. Farallon Capital Management 0.02%

holders

sorted by % of portfolio · long equity only · open a manager for their book

history
Cathie Wood - Ark Investment Management 2026 Q2 0.2% Add +33.6% 8,348,746 $31M hist
Farallon Capital Management 2026 Q2 0.02% Hold 1,240,843 $5M hist

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $2.98M $4.63M
Gross profit — — —
Gross margin — — —
Net income -$198.13M -$195.88M -$201.14M
Net margin * — -6566.6% -4342.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $142.98M $211.89M $181.29M
Total non-current assets * $50.88M $85.62M $161.44M
Total assets $193.85M $297.51M $342.73M
Total current liabilities $56.42M $37.96M $37.45M
Total non-current liabilities * $4.36M $106.4M $184.42M
Total equity $133.07M $153.15M $120.87M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$165.41M -$122.86M -$162.56M
Cash from investing $18.71M $68.46M -$108.76M
Cash from financing $655,000 $195.88M $151.51M
Net change in cash -$146.05M $141.47M -$119.82M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders